Hui-Chun Yu

560 citations
24 papers · 468 indexed · h-index 14
Topics
Spondyloarthritis Studies and Treatments (7 papers)Autoimmune and Inflammatory Disorders Research (7 papers)Galectins and Cancer Biology (4 papers)

In The Last Decade

Hui-Chun Yu

23 papers receiving 464 citations

Peers

Hui-Chun Yu
Comparison fields: 5 of 73
  • Molecular Biology 214
  • Rheumatology 143
  • Immunology 137
  • Cancer Research 116
  • Microbiology 97
Replace Michael J. Pattison with:
Michael J. Pattison United Kingdom
Meirav Zaks‐Zilberman United States
Vivian B. Weg United States
Špela Konjar Portugal
Richard Widstrom United States
Constance Capodici United States
Lisette Bevaart Netherlands
Bassam Badran Belgium
Uri Sela Israel
Atsushi Matsui Japan
Hui-Chun Yu relative to Michael J. Pattison United Kingdom Michael J. Pattison's profile →
Citations per field
00.5×4.6×
Michael J. Pattison · 1×
Citations per year

Countries citing papers authored by Hui-Chun Yu

Since Specialization
Citations

This map shows the geographic impact of Hui-Chun Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui-Chun Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui-Chun Yu more than expected).

Fields of papers citing papers by Hui-Chun Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hui-Chun Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui-Chun Yu. The network helps show where Hui-Chun Yu may publish in the future.

Co-authorship network of co-authors of Hui-Chun Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Hui-Chun Yu. A scholar is included among the top collaborators of Hui-Chun Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hui-Chun Yu. Hui-Chun Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 5
3 16
4 17
5 21
6 2
7 13
8 36
9 17
10 57
11 3
12 14
13 15
14 11
15 43
16 3
17 8
18 114
19 14
20 31

About Hui-Chun Yu

Hui-Chun Yu is a scholar working on Rheumatology, Immunology and Hematology, having authored 24 papers that have together received 468 indexed citations. Recurring topics across this work include Spondyloarthritis Studies and Treatments (7 papers), Autoimmune and Inflammatory Disorders Research (7 papers) and Galectins and Cancer Biology (4 papers). The work is most often cited by research in Microbiology (97 citations), Rheumatology (143 citations) and Cancer Research (116 citations). Hui-Chun Yu has collaborated with scholars based in Taiwan, United States and Canada. Frequent co-authors include Ming‐Chi Lu, Ning‐Sheng Lai, Hsien‐Bin Huang, Chien‐Hsueh Tung, Kuang‐Yung Huang, Chia‐Li Yu, Shih‐Bin Lin, Hung-Ta Chou, Wei‐Jung Chen and Tsun‐Yung Kuo. Their work appears in journals such as PLoS ONE, International Journal of Molecular Sciences and Frontiers in Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026